+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
From
From
Gallbladder Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Gallbladder Cancer Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 166 Pages
  • Global
From
Immunotherapy Drugs Market 2024-2028 - Product Thumbnail Image

Immunotherapy Drugs Market 2024-2028

  • Report
  • November 2023
  • 163 Pages
  • Global
From
Antibody Drug Conjugates Market 2024-2028 - Product Thumbnail Image

Antibody Drug Conjugates Market 2024-2028

  • Report
  • November 2023
  • 156 Pages
  • Global
From
From
USA Solid Tumor Therapeutics Market Outlook to 2028 - Product Thumbnail Image

USA Solid Tumor Therapeutics Market Outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
From
Anti-Hypertensive Drugs Global Market Report 2024 - Product Thumbnail Image

Anti-Hypertensive Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Atherosclerosis Drugs Global Market Report 2024 - Product Thumbnail Image

Atherosclerosis Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Hypertrophic Cardiomyopathy Treatment Global Market Report 2024 - Product Thumbnail Image

Hypertrophic Cardiomyopathy Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Loading Indicator